Retatrutide 6mg/1ml & 12mg/1ml | Dual-Chamber Pen

Why is the Dual-Chamber Pen different? The Dual-Chamber Pen is an innovative peptide delivery system designed to address one of the main challenges when working with peptide solutions – the loss of stability after reconstitution. With this technology, the lyophilized peptide and the liquid phase are stored in two completely independent and hermetically sealed chambers, preventing any contact between the components until the moment of activation. This separation eliminates the risk of premature reconstitution and significantly reduces the likelihood of chemical or physical degradation of the active compound during storage and transport. As a result, the peptide retains its structural integrity and characteristics in its lyophilized form until the moment of use, when it is most needed. The Dual-Chamber system allows mixing to be carried out in a controlled and precise manner immediately before use, ensuring a higher level of stability, freshness, and consistency of the resulting solution. In this way, an optimal balance is achieved between the reliability of a standard lyophilized vial and the convenience and precision of a pen, without additional steps, complex preparation, or compromises in quality. What is Retatrutide? Retatrutide is a next-generation experimental peptide developed to target key regulatory mechanisms of energy balance and metabolism. It is a so-called triple agonist that simultaneously activates GLP-1, GIP, and glucagon receptors – a combination aimed at both appetite control and increased energy expenditure. Through this multi-directional mechanism, Retatrutide influences central appetite regulation, peripheral metabolism, and nutrient processing, distinguishing it from earlier generations of incretin agonists. What are the potential benefits of Retatrutide? The potential benefits of Retatrutide are associated with its complex effects on appetite, glucose metabolism, and energy expenditure: Appetite control – supports hunger reduction through central satiety mechanisms. Influence on energy expenditure – activation of the glucagon receptor contributes to increased metabolic activity. Support for significant body weight reduction – through combined effects on energy intake and expenditure. Optimization of glucose metabolism – supports more stable blood glucose control. Overall improvement of the metabolic profile – with potential positive effects on body composition and insulin sensitivity. How is Retatrutide dosed with a Dual-Chamber Pen? Dosage and concentration of Retatrutide 6mg/1ml: 1 unit = 60 mcg Retatrutide Total content: 100 units (6 mg) in one Dual-Chamber Pen Recommended dosing levels for 6mg/1ml: Starting dose: 33.5 units (2 mg) Moderate dose: 66.5 units (4 mg) Increased dose: 100 units (6 mg) Dosage and concentration of Retatrutide 12mg/1ml: 1 unit = 120 mcg Retatrutide Total content: 100 units (12 mg) in one Dual-Chamber Pen Recommended dosing levels for 12mg/1ml: Starting dose: 16.5 units (2 mg) Moderate dose: 33.5 units (4 mg) Increased dose: 50 units (6 mg) Once-weekly administration is recommended. Duration may vary depending on the protocol, user age, and research objectives. A break between cycles is recommended.